GlassScriptPhysician profile
Kyrollis Attalla
NPI 1912326174
$380,988.35
in general payments reported to CMS, 2019-2025
29 companies · $231K in 2025
The $231K reported for 2025 was more than what 99% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.03 · 2022: $412 · 2023: $23K · 2024: $126K · 2025: $231K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $351K · Food and Beverage: $14K · Travel and Lodging: $8,845 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,125 · Education: $592 · Entertainment: $203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $351,133.23 |
| Food and Beverage | $13,655.98 |
| Travel and Lodging | $8,844.87 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,125.00 |
| Education | $592.48 |
| Entertainment | $202.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edap Technomed INC | $353,817.87 | 2022-2025 | Focal One |
| Koelis INC. | $23,611.75 | 2022-2025 | |
| Profound Medical Corp. | $625.37 | 2025 | Tulsa-Pro |
| Pfizer INC. | $426.14 | 2019-2025 | |
| Endo USA, INC. | $253.02 | 2024-2025 | Xiaflex, Aveed, Edex |
| Progenics Pharmaceuticals, INC. | $220.87 | 2023-2025 | Pylarify |
| Sumitomo Pharma America, INC. | $208.76 | 2023-2025 | Orgovyx, Gemtesa |
| Coloplast Corp | $184.97 | 2022-2025 | |
| Urogen Pharma, INC. | $181.09 | 2024-2025 | |
| Tolmar, INC. | $169.56 | 2023-2025 | Eligard |
| Blue Earth Diagnostics | $160.63 | 2023-2024 | |
| Civco Medical Instruments | $138.51 | 2023-2024 | |
| Astellas Pharma US INC | $122.98 | 2023-2025 | Xtandi, Myrbetriq |
| Merck Sharp & Dohme LLC | $120.58 | 2023-2025 | Keytruda |
| Bayer Healthcare Pharmaceuticals INC. | $115.19 | 2023-2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $90.83 | 2025 | Bd Onclarity |
| Boston Scientific Corporation | $88.17 | 2022-2023 | |
| Abc Home Medical Supply, INC. | $80.04 | 2023-2024 | |
| Laborie Medical Technologies Corp. | $57.16 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Janssen Biotech, INC. | $53.42 | 2025 | Erleada |
| Hollister Incorporated | $51.10 | 2024 | Vapro, Infyna Chic, Onli |
| Teleflex LLC | $41.09 | 2023-2024 | Solesta, Urolift |
| Dentsply Ih Ab | $32.32 | 2025 | Lofric |
| Angiodynamics, INC. | $25.15 | 2023 | Nanoknife |
| Endo Pharmaceuticals INC. | $24.50 | 2023 | Aveed, Xiaflex, Edex |
| Tolmar Pharmaceuticals, INC. | $24.03 | 2022 | |
| Olympus America INC. | $22.06 | 2025 | Itind System |
| Integra Lifesciences Corporation | $20.85 | 2023 | Integra, Omnigraft, Surgimend |
| Medtronic, INC. | $20.34 | 2025 | V-Loc 180 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyrollis Attalla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.